Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis

被引:191
|
作者
Gao, YK
Herndon, JM
Zhang, H
Griffith, TS
Ferguson, TA
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 188卷 / 05期
关键词
apoptosis; inflammation; immune privilege; FasL; interleukin-10;
D O I
10.1084/jem.188.5.887
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Apoptosis is critical to homeostasis of multicellular organisms. In immune privileged sites such as the eye, CD95 ligand (FasL)-induced apoptosis controls dangerous inflammatory reactions that can cause blindness. Recently, we demonstrated that apoptotic cell death of inflammatory cells was a prerequisite for the induction of immune deviation after antigen presentation in the eye. In this report, we examine the mechanism by which this takes place. Our results show that Fas-mediated apoptosis of lymphoid cells leads to rapid production of interleukin (IL)-10 in these cells. The apoptotic cells containing IL-10 are responsible for the activation of immune deviation through interaction with antigen-presenting cells (APC). In support of this, we found that apoptotic cells from IL-10(+/+) animals fed to APC in vitro promote Th2 cell differentiation, whereas apoptotic IL-10(-/-) cells, as well as nonapoptotic cells, favor Th1 induction. Thus, apoptotic cell death and tolerance are linked through the production of an antiinflammatory cytokine to prevent dangerous and unwanted immune responses that might compromise organ integrity.
引用
收藏
页码:887 / 896
页数:10
相关论文
共 50 条
  • [21] Characterisation of the roles of CD95 and CD95 ligand in cord blood
    Drénou, B
    Choqueux, C
    El Ghalbzouri, A
    Blancheteau, V
    Toubert, A
    Charron, D
    Mooney, N
    BONE MARROW TRANSPLANTATION, 1998, 22 : S44 - S47
  • [22] CD137-induced apoptosis is independent of CD95
    Michel, J
    Pauly, S
    Langstein, J
    Krammer, PH
    Schwarz, H
    IMMUNOLOGY, 1999, 98 (01) : 42 - 46
  • [23] CD95 and CD95 ligand expression in very thin melanoma
    Fearfield, LA
    Rowe, A
    Francis, N
    Fisher, C
    MacKie, RM
    Gore, ME
    Bunker, CB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 554 - 554
  • [24] Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
    Glick, RD
    Swendeman, SL
    Coffey, DC
    Rifkind, RA
    Marks, PA
    Richon, VM
    La Quaglia, MP
    CANCER RESEARCH, 1999, 59 (17) : 4392 - 4399
  • [25] CD95 (APO-1/FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS
    DANIEL, PT
    MAPARA, MY
    BOMMERT, K
    BARGOU, RC
    KRAMMER, P
    DORKEN, B
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 831 - 831
  • [26] Trophoblast apoptosis in chorioamnionitis: Possible role for FasL (CD95L) and its receptor Fas (CD95)
    Balkundi, DR
    Ziegler, J
    Watchko, JF
    Trucco, M
    PEDIATRIC RESEARCH, 2002, 51 (04) : 57A - 57A
  • [27] Role of the CD95/CD95-ligand system in radiogenically induced pneumonitis
    Heinzelmann, F
    Boras, R
    Handrick, R
    Henkel, M
    Nowak, K
    Jendrossek, V
    Budach, W
    Bamberg, M
    Belka, C
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 92 - 92
  • [28] CD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes
    Reinehr, R
    Görg, B
    Höngen, A
    Häussinger, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) : 10364 - 10373
  • [29] Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis
    Hueber, AO
    Zornig, M
    Lyon, D
    Suda, T
    Nagata, S
    Evan, GI
    SCIENCE, 1997, 278 (5341) : 1305 - 1309
  • [30] Posttranscriptional control of the apoptosis-inducing Fas (CD95) ligand
    Brunner, T
    TISSUE ANTIGENS, 2004, 64 (04): : 341 - 341